Onayan, Rosemarie D.
HRN: 28-21-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
METRONIDAZOLE 500MG (TAB)
12/03/2025
12/13/2025
PO
500mg
TID
Intestinal Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes